Top rated prostate cancer clinical trials in High Point, North Carolina
Here are the top 10 medical studies for prostate cancer in High Point, North Carolina
Popular filter options for prostate-cancer high-point trials
Phase 3 Clinical Trials
View 76 phase 3 medical studies.
Hormone Therapy
Antiandrogen + Radiation +/- Docetaxel for Prostate Cancer
Recruiting1 awardPhase 2 & 3
Savannah, Georgia
This trial is testing docetaxel in combination with antiandrogen therapy and radiation therapy versus antiandrogen therapy and radiation therapy alone in treating patients with prostate cancer that has been removed by surgery.
Cancer Vaccine
ProstAtak® Immunotherapy + Radiation for Prostate Cancer
Recruiting1 awardPhase 3
Salem, Virginia
This trial is testing whether adding ProstAtak immunotherapy to radiation therapy can improve outcomes for patients with localized prostate cancer at high or intermediate risk for the disease coming back.
Hormone Therapy
Standard Therapy + Surgery/Radiation for Prostate Cancer
Recruiting2 awardsPhase 3
Augusta, Georgia
This trial is testing whether adding surgery or radiation therapy to standard treatment for prostate cancer that has spread to other parts of the body lowers the chance of the cancer growing or spreading.
Clinical Trials With No Placebo
View 76 medical studies that do not have a placebo group.
Hormone Therapy
Antiandrogen + Radiation +/- Docetaxel for Prostate Cancer
Recruiting1 awardPhase 2 & 3
Savannah, Georgia
This trial is testing docetaxel in combination with antiandrogen therapy and radiation therapy versus antiandrogen therapy and radiation therapy alone in treating patients with prostate cancer that has been removed by surgery.
Corticosteroid
Abiraterone + Prednisone/Olaparib for Prostate Cancer
Recruiting3 awardsPhase 2
Chapel Hill, North Carolina
This trial is testing a new cancer treatment for men with metastatic castration resistant prostate cancer. It is a 1:1:1 randomized open-label multicenter phase II study, which means that patients will be randomly assigned to one of three different treatment groups. The study will take place at multiple centers, and patients will be observed over the course of the trial.
Checkpoint Inhibitor
Pembrolizumab Combination Therapies for Prostate Cancer
Recruiting1 awardPhase 1 & 2
Cary, North Carolina
This trial will assess the safety and efficacy of pembrolizumab in combination with other drugs for treating patients with mCRPC. There will be nine cohorts in the study, each receiving different combinations of drugs. Outcome measures will be assessed individually for each cohort.
View More Prostate-cancer High-point Trials
See another 61 medical studies focused on prostate-cancer high-point.
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.